These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 5329616)

  • 1. Effects of clofibrate and dextrothyroxine singly and in combination on serum lipids.
    Best MM; Duncan CH
    Arch Intern Med; 1966 Aug; 118(2):97-102. PubMed ID: 5329616
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of a new drug (CH 13437) in the treatment of hyperlipemia].
    Arteaga A; Foradori A; Eyzaguirre J; Lira P; Vasquez A; Soto S; Alliende ME; Guzman L
    Rev Med Chil; 1970 Oct; 98(10):689-94. PubMed ID: 4927028
    [No Abstract]   [Full Text] [Related]  

  • 3. Clofibrate and dextrothyroxine in coronary heart diseases. A clinical and biochemical study.
    Bhatia ML; Setty KR; Roy SB
    J Assoc Physicians India; 1971 Feb; 19(2):123-9. PubMed ID: 4934418
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of diet changes and use of dextrothyroxine and chlorphenisate on serum lipids].
    Arteaga A; Cisternas H; Torres MC; Alliende ME
    Rev Med Chil; 1969 May; 97(5):285-90. PubMed ID: 5386042
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of hyperlipoproteinemias (author's transl)].
    Crepaldi G; Fellin R; Briani G; Baggio G; Baiocchi MR
    G Ital Cardiol; 1974; 4(3):332-40. PubMed ID: 4367439
    [No Abstract]   [Full Text] [Related]  

  • 6. The coronary drug project. Design, methods, and baseline results.
    Circulation; 1973 Mar; 47(3 Suppl):I1-50. PubMed ID: 4570454
    [No Abstract]   [Full Text] [Related]  

  • 7. The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group.
    JAMA; 1973 Nov; 226(6):652-7. PubMed ID: 4356847
    [No Abstract]   [Full Text] [Related]  

  • 8. Clofibrate and androsterone effect on serum lipids.
    Orgain ES; Bogdonoff MD; Cain C
    Arch Intern Med; 1967 Jan; 119(1):80-5. PubMed ID: 6015838
    [No Abstract]   [Full Text] [Related]  

  • 9. The efficacy of lipid lowering drugs alone and in combination.
    Hansen PF
    Postgrad Med J; 1975; 51(8):63-5. PubMed ID: 768949
    [No Abstract]   [Full Text] [Related]  

  • 10. The Coronary Drug Project. Initial findings leading to modifications of its research protocol.
    JAMA; 1970 Nov; 214(7):1303-13. PubMed ID: 4320008
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes induced by D-thyroxine treatment in blood lipid indices in arteriosclerotic subjects].
    Notarbartolo A; Di Fede G; Cupidi G; Rini GB
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):979-83. PubMed ID: 4463989
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of hyperlipidemic states.
    Strisower EH; Adamson G; Strisower B
    Med Clin North Am; 1970 Nov; 54(6):1599-613. PubMed ID: 5487683
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of clofibrate on raised serum lipid levels.
    Smith RB; Prior IA; Cooke NJ
    N Z Med J; 1968 Oct; 68(437):231-4. PubMed ID: 5247681
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
    Bergqvist N
    Acta Med Scand; 1970 Mar; 187(3):213-8. PubMed ID: 5444978
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of dyslipemias with the association of dx-thyroxine and choleretics].
    Martinelli M; Albini U; Villecco A
    Boll Soc Ital Cardiol; 1970; 15(6):539-43. PubMed ID: 5517650
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative studies of the lipid-lowering activity of etiroxate hydrochloride and dextrothyroxine (author's transl)].
    Schwartzkopff W; Russ E
    MMW Munch Med Wochenschr; 1975 May; 117(19):827-30. PubMed ID: 805950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative.
    Oriente P; Motolese M; Cerqua R; Mancini M
    Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):348-53. PubMed ID: 4903988
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term changes of serum cholesterol with cholesterol-altering drugs in patients with coronary heart disease. Veterans Administration Drug-Lipid Cooperative Study.
    Detre KM; Shaw L
    Circulation; 1974 Nov; 50(5):998-1005. PubMed ID: 4609636
    [No Abstract]   [Full Text] [Related]  

  • 20. [Action of the new hypocholesteremic agent DH-581 (dithiobisphenol) in humans].
    Brusco OJ; Oriozabala MA; Arakaki R
    Prensa Med Argent; 1971 Oct; 58(32):1587-94. PubMed ID: 4943247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.